Will Nvidia Stock Rally After Its Q3 Earnings Report? — Positive
NVDA Investors Business Daily — November 17, 2025Analysts are wondering if Nvidia CEO Jensen Huang can say anything that will drive Nvidia stock higher after its Q3 report.
Zymeworks Surges On Positive Ziihera Phase 3 Data: Expanding First-Line GEA Opportunity — Positive
ZYME Seeking Alpha — November 17, 2025Zymeworks Inc. (ZYME) surged after positive Phase 3 results for Ziihera in first-line HER2-positive gastroesophageal adenocarcinoma, expanding its FDA-approved indications. ZYME's partnership-driven model, strong cash position, and milestone revenues limit capital risk and provide a projected runway into 2H27. The positive Ziihera data supports regulatory submission in 2026, with key catalysts including full data presentation and sBLA filing, and potential label expansion.
CarMax, Inc. (KMX) Investors: January 2, 2026 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP — Neutral
KMX PRNewsWire — November 17, 2025RADNOR, Pa. , Nov. 17, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that an amended securities class action lawsuit has been filed against CarMax, Inc. ("CarMax") (NYSE: KMX) which expands the class period to include those who purchased or otherwise acquired CarMax securities between June 20, 2025, and November 5, 2025, inclusive (the "Class Period").
U.S. Investigators Probe Exec Facing Fraud Allegations From BlackRock's HPS — Negative
BLK WSJ — November 17, 2025Federal officials have opened a criminal investigation into Bankim Brahmbhatt, who was sued by HPS and other lenders earlier this year.
CYTK DEADLINE: ROSEN, GLOBAL INVESTOR RIGHTS COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action - CYTK — Neutral
CYTK Newsfile Corp — November 17, 2025New York, New York--(Newsfile Corp. - November 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ: CYTK) between December 27, 2023 and May 6, 2025, both dates inclusive (the "Class Period"), of the important November 17, 2025 lead plaintiff deadline. SO WHAT: If you purchased Cytokinetics common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Update On The Chinese Large-Cap FXI ETF: Risky But Undervalued — Positive
FXI Seeking Alpha — November 17, 2025iShares China Large-Cap ETF offers significant upside potential as Chinese stocks remain undervalued compared to global peers. FXI has shown a strong bullish trend since early 2024, with technical resistance at $42 and upside targets at $54.52 and $73.19. FXI boasts high liquidity and momentum grades, but investors should be mindful of U.S.-China tensions and FXI's expense ratio.
Goldman Sachs sees oil prices falling through 2026 on supply surge — Negative
BNO DBO GUSH IEO OIH OIL PXJ UCO USO XOP Reuters — November 17, 2025Oil prices are expected to decline through 2026, Goldman Sachs said on Monday, citing a production surge that will keep the market in a large surplus of around 2 million barrels per day.
Ecolab Launches Integrated Cooling Platform to Support AI Data Centers — Positive
ECL Zacks Investment Research — November 17, 2025ECL's new Cooling as a Service platform targets soaring AI data center demand with integrated site-to-chip efficiency upgrades.
Bit Digital draws continued analyst support as it expands Ethereum treasury — Positive
BTBT Proactive Investors — November 17, 2025Analysts at Noble Capital Markets have repeated their ‘Outperform' rating on Bit Digital Inc (NASDAQ:BTBT) following its latest quarterly results, which marked the company's first full reporting period as an Ethereum (ETH)-focused treasury and staking operation. Their price target of $5.50 implies upside of about 140% from current levels.
AmEx Flies 20.4% YTD: Should Investors Tap in Before it Boards? — Positive
AXP Zacks Investment Research — November 17, 2025AmEx's 20.4% YTD surge, strong valuation edge and resilient premium spenders raise the question of where the card giant heads next.
All Eyes on Nvidia: Could This Week's Earnings Define the AI Investment Era? — Neutral
NVDA FXEmpire — November 17, 2025The intense focus on Nvidia's quarterly results stems from a fundamental tension now gripping financial markets.
US Dollar Forecast: DXY Steadies as FOMC Minutes and Data Deluge Move Into Focus — Neutral
AAAU DGL DGP GLD GLDM IAU IAUF OUNZ UGL FXEmpire — November 17, 2025DXY leans higher as traders await U.S. jobs report and FOMC minutes. Market eyes key pivot at 99.306, with data and rate clues likely to drive direction.
3 Energy Giants Amp Up Dividends—Here's What It Means for Investors — Positive
CCJ COP XOM MarketBeat — November 17, 2025Three energy behemoths are lifting their dividends—a Dividend Aristocrat, a huge nuclear name, and one of the world's largest oil exploration and production companies. For income-focused investors, these moves offer compelling entry points across oil and nuclear energy, whether you're seeking yield stability, growth potential, or sector diversification.
SPRU's Q3 Loss Narrows Y/Y on NJR Acquisition and Cost Cuts, Stock Up 73% — Positive
SPRU Zacks Investment Research — November 17, 2025Spruce Power posted a narrower year-over-year loss in Q3 and showed strong revenue growth from the NJR portfolio and improved margins from cost reductions, signaling momentum in its solar servicing and subscription business.
DXCM Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against DexCom, Inc. (DXCM) — Neutral
DXCM PRNewsWire — November 17, 2025RADNOR, Pa. , Nov. 17, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against DexCom, Inc. ("DexCom") (NASDAQ: DXCM) on behalf of those who purchased or otherwise acquired DexCom securities between January 8, 2024, and September 17, 2025, inclusive (the "Class Period").
Top Stock Movers Now: Google Parent Alphabet, Dell, HP, and More — Positive
GOOG GOOGL Investopedia — November 17, 2025Major U.S. equities indexes were mixed and little changed at midday Monday ahead of a slew of earnings reports from big retailers and tech companies expected later this week. The S&P 500 and Nasdaq were slightly higher, while the Dow edged lower.
Analyst says Nvidia's setup for 2026 is 'very strong,' expectations on Fed's December rate decision — Positive
NVDA Yahoo Finance — November 17, 2025Market Catalysts anchor Julie Hyman breaks down the latest market news for November 17, 2025. Nvidia is set to report earnings on Wednesday, November 19.
Here's Why Investors Should Give Norfolk Southern Stock a Miss Now — Negative
NSC Zacks Investment Research — November 17, 2025NSC faces rising costs, weak liquidity and tariff pressures, with falling estimates and share declines underscoring mounting investor concerns.
Bullish to Report Q3 Earnings: What's in Store for the Stock? — Positive
BLSH Zacks Investment Research — November 17, 2025BLSH's third-quarter performance is expected to have benefited from strong subscription gains and momentum across Liquidity Services and CoinDesk products.
Give Your Back a Break this Holiday with The Joint Chiropractic's "Back Friday Deals" — Neutral
JYNT PRNewsWire — November 17, 2025SCOTTSDALE, Ariz. , Nov. 17, 2025 /PRNewswire/ -- The holidays can feel like a full-contact sport for your back.